Reduction of Serious Adverse Events (SAE) under palbociclib treatment in patients using an interactive eHealth system

Schmidt M, Degenhardt T, Fasching P, Lüftner D, Müller V, Thomssen C, Schem C, Witzel I, Decker T, Tesch H, Kümmel S, Uleer C, Würstlein R, Hoffmann O, Warm M, Marschner N, Kates RE, Schumacher J, Harbeck N (2020)

Publication Type: Journal article

Publication year: 2020

Journal

European Journal of Cancer Elsevier

Book Volume: 138

Pages Range: S68-

DOI: 10.1016/S0959-8049(20)30709-7

Authors with CRIS profile

Peter Fasching Professur für Translationale Frauenheilkunde und Geburtshilfe

Involved external institutions

Charité - Universitätsmedizin Berlin

Germany (DE) Kliniken Essen-Mitte

Germany (DE) Universität Hildesheim

Germany (DE) Ludwig-Maximilians-Universität (LMU)

Germany (DE) iOMEDICO AG

Germany (DE) Universitätsmedizin der Johannes Gutenberg-Universität Mainz

Germany (DE) Universitätsklinikum Hamburg-Eppendorf (UKE)

Germany (DE) Martin-Luther-Universität Halle-Wittenberg (MLU)

Germany (DE) Universitätsklinikum Essen

Germany (DE) palleos healthcare GmbH

Germany (DE) Westdeutsche Studiengruppe GmbH (WSG) / Women's healthcare Study Group

Germany (DE) Krankenhaus Köln-Holweide

Germany (DE) Krankenhaus Jerusalem

Germany (DE)

How to cite

APA:

Schmidt, M., Degenhardt, T., Fasching, P., Lüftner, D., Müller, V., Thomssen, C.,... Harbeck, N. (2020). Reduction of Serious Adverse Events (SAE) under palbociclib treatment in patients using an interactive eHealth system. European Journal of Cancer, 138, S68-. https://doi.org/10.1016/S0959-8049(20)30709-7

MLA:

Schmidt, M., et al. "Reduction of Serious Adverse Events (SAE) under palbociclib treatment in patients using an interactive eHealth system." European Journal of Cancer 138 (2020): S68-.

BibTeX: Download